Pharmaceuticals: United States Industry Guide is an essential resource for top-level data and analysis covering the United States Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Highlights
* The United States biotechnology market grew by 11.3% in 2007 to reach a value of $84,760 million.
* The US generics market generated total revenues of $30.8 billion in 2007, representing a compound annual growth rate (CAGR) of 16.8% for the period spanning 2003-2007.
* The United States OTC pharmaceuticals market generated total revenues of $25.5 billion in 2008, representing a compound annual growth rate (CAGR) of 3.4% for the period spanning 2004-2008.
* The United States market generated total revenues of $273.9 billion in 2008, representing a compound annual growth rate (CAGR) of 3.7% for the period spanning 2004-2008.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
CHAPTER 1 BIOTECHNOLOGY IN THE UNITED STATES 10
1.1 Market Overview 10
1.2 Market Value 12
1.3 Market Segmentation I 13
1.4 Market Segmentation II 14
1.5 Five Forces Analysis 15
1.6 Market Forecasts 21
CHAPTER 2 GENERICS IN THE UNITED STATES 22
2.1 Market Overview 22
2.2 Market Value 24
2.3 Market Segmentation I 25
2.4 Market Segmentation II 26
2.5 Five Forces Analysis 27
2.6 Market Forecasts 34
CHAPTER 3 OTC PHARMACEUTICALS IN THE UNITED STATES 35
3.1 Market Overview 35
3.2 Market Value 37
3.3 Market Segmentation I 38
3.4 Market Segmentation II 39
3.5 Market Share 40
3.6 Five Forces Analysis 41
3.7 Distribution 48
3.8 Market Forecasts 49
CHAPTER 4 PHARMACEUTICALS IN THE UNITED STATES 50
4.1 Market Overview 50
4.2 Market Value 52
4.3 Market Segmentation I 53
4.4 Market Segmentation II 54
4.5 Market Share 55
4.6 Five Forces Analysis 56
4.7 Market Forecasts 63
CHAPTER 5 DEMOGRAPHICS 64
CHAPTER 6 APPENDIX 65
6.1 Data Research Methodology 65
LIST OF TABLES
Table 1: United States Biotechnology Market Value: $ million, 2003-2007 12
Table 2: United States Biotechnology Market Segmentation I: % Share, by Volume, 2007 13
Table 3: United States Biotechnology Market Segmentation II: % Share, by Value, 2007 14
Table 4: United States Biotechnology Market Value Forecast: $ million, 2007-2012 21
Table 5: United States Generics Market Value: $ billion, 2003-2007 24
Table 6: United States Generics Market Segmentation I: % Share, by Value, 2007 25
Table 7: United States Generics Market Segmentation II: % Share, by Value, 2007 26
Table 8: United States Generics Market Value Forecast: $ billion, 2007-2012 34
Table 9: United States OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 37
Table 10: United States OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 38
Table 11: United States OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 39
Table 12: United States OTC Pharmaceuticals Market Share: % Share, by Value, 2007 40
Table 13: United States OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 48
Table 14: United States OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 49
Table 15: United States Pharmaceuticals Market Value: $ million, 2003-2007 52
Table 16: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 53
Table 17: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 54
Table 18: United States Pharmaceuticals Market Share: % Share, by Value, 2007 55
Table 19: United States Pharmaceuticals Market Value Forecast: $ million, 2007-2012 63
Table 20: United States Size of Population (million) , 2003-2007 64
Table 21: United States GDP (Constant 2000 Prices, $ billion), 2003-2007 64
Table 22: United States Inflation, 2003-2007 64
LIST OF FIGURES
Figure 1: United States Biotechnology Market Value: $ million, 2003-2007 12
Figure 2: United States Biotechnology Market Segmentation I: % Share, by Volume, 2007 13
Figure 3: United States Biotechnology Market Segmentation II: % Share, by Value, 2007 14
Figure 4: Forces Driving Competition in the Biotechnology Market in the US, 2007 15
Figure 5: Drivers of Buyer Power in the Biotechnology Market in the US, 2007 16
Figure 6: Drivers of Supplier Power in the Biotechnology Market in the US, 2007 17
Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in the US, 2007 18
Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology Market in the US, 2007 19
Figure 9: Drivers of Degree of Rivalry in the Biotechnology Market in the US, 2007 20
Figure 10: United States Biotechnology Market Value Forecast: $ million, 2007-2012 21
Figure 11: United States Generics Market Value: $ billion, 2003-2007 24
Figure 12: United States Generics Market Segmentation I: % Share, by Value, 2007 25
Figure 13: United States Generics Market Segmentation II: % Share, by Value, 2007 26
Figure 14: Forces Driving Competition in the Generics Market in the United States, 2007 27
Figure 15: Drivers of Buyer Power in the Generics Market in the United States, 2007 29
Figure 16: Drivers of Supplier Power in the Generics Market in the United States, 2007 30
Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in the United States, 2007 31
Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in the United States, 2007 32
Figure 19: Drivers of Degree of Rivalry in the Generics Market in the United States, 2007 33
Figure 20: United States Generics Market Value Forecast: $ billion, 2007-2012 34
Figure 21: United States OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 37
Figure 22: United States OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 38
Figure 23: United States OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 39
Figure 24: United States OTC Pharmaceuticals Market Share: % Share, by Value, 2007 40
Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in the United States 41
Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in the United States 42
Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in the United States 43
Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in the United States 44
Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in the United States 46
Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in the United States 47
Figure 31: United States OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 48
Figure 32: United States OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 49
Figure 33: United States Pharmaceuticals Market Value: $ million, 2003-2007 52
Figure 34: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 53
Figure 35: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 54
Figure 36: United States Pharmaceuticals Market Share: % Share, by Value, 2007 55
Figure 37: Forces Driving Competition in the Pharmaceuticals Market in the US, 2007 56
Figure 38: Drivers of Buyer Power in the Pharmaceuticals Market in the US, 2007 57
Figure 39: Drivers of Supplier Power in the Pharmaceuticals Market in the US, 2007 58
Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the US, 2007 60
Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the US, 2007 61
Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the US, 2007 62
Figure 43: United States Pharmaceuticals Market Value Forecast: $ million, 2007-2012 63
Other selected research from the 'USA' category:
The Pharmaceutical Parallel Trade Outlook: Challenges to pharmaceutical companies across Europe and the US
OTC Pharmaceuticals - North America (NAFTA) Industry Guide
Other selected research from the 'Markets' category:
The Future of Monoclonal Antibodies Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011
Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family